Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Disorders of Leukocytes01:27

Disorders of Leukocytes

1.7K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.7K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

672
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
672
Overview of Metabolism01:40

Overview of Metabolism

37.5K
Living cells constantly carry out various chemical reactions which are necessary for their proper functioning. These reactions are interlinked to one another via multiple pathways. The collection of these chemical reactions is known as metabolism.
Plant Metabolism
Sunlight, the primary source of energy in plants, is first absorbed by the chlorophyll pigments present in their leaves. Plants then use this energy to carry out photosynthesis, where water is oxidized into oxygen and carbon dioxide...
37.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Reduced expression but not deficiency of GFI1 causes a fatal myeloproliferative disease in mice.

Leukemia·2026
Same author

Single cell-resolved cellular, transcriptional, and epigenetic changes in mouse T cell populations linked to age-associated immune decline.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

An inflammatory state defines a high-risk T-lineage acute lymphoblastic leukemia subgroup.

Science translational medicine·2025
Same author

An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia.

bioRxiv : the preprint server for biology·2024
Same author

An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia.

Cancer research·2024
Same author

Combination of menin and kinase inhibitors as an effective treatment for leukemia with NUP98 translocations.

Leukemia·2024

Related Experiment Video

Updated: Jan 4, 2026

Assessment of the Metabolic Profile of Primary Leukemia Cells
06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

10.9K

Metabolic dependencies and vulnerabilities in leukemia.

Marissa Rashkovan1, Adolfo Ferrando1,2,3

  • 1Institute for Cancer Genetics, Columbia University, New York, NY 10032, USA.

Genes & Development
|November 3, 2019
PubMed
Summary

Leukemia cells rewire metabolism for growth and survival. Targeting these metabolic pathways offers new therapeutic strategies for leukemia treatment.

Keywords:
Warburg effectglycolysisleukemiametabolismmitochondriatargeted therapy

More Related Videos

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.5K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.7K

Related Experiment Videos

Last Updated: Jan 4, 2026

Assessment of the Metabolic Profile of Primary Leukemia Cells
06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

10.9K
Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.5K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.7K

Area of Science:

  • Oncology
  • Molecular Biology
  • Metabolic Research

Background:

  • Leukemia cell proliferation depends on altered metabolic pathways to support rapid growth.
  • Aberrant cellular metabolism is a hallmark of cancer, crucial for leukemia cell survival and progression.
  • Metabolic reprogramming is linked to oncogene addiction, presenting therapeutic vulnerabilities.

Purpose of the Study:

  • To review the metabolic pathways supporting leukemia anabolism, redox balance, and energy production.
  • To highlight emerging therapeutic opportunities targeting leukemia metabolism.
  • To explore the role of metabolic circuitries in leukemia progression and survival.

Main Methods:

  • Literature review of studies on leukemia metabolism.
  • Analysis of metabolic pathways involved in cancer cell growth.
  • Identification of therapeutic targets in leukemia metabolic reprogramming.

Main Results:

  • Leukemia cells exhibit significant metabolic rewiring to meet the demands of proliferation.
  • Metabolic pathways are critical for maintaining redox homeostasis and energy supply in leukemia cells.
  • Targeting metabolic dependencies shows promise for novel anti-leukemia therapies.

Conclusions:

  • Understanding leukemia metabolic circuitries is essential for developing effective treatments.
  • Aberrant metabolism represents a key vulnerability in leukemia that can be therapeutically exploited.
  • Targeted therapies focusing on metabolic pathways offer a promising avenue for future leukemia treatment strategies.